CALCiViS News

CALCiViS announces FDA filing of the Pre-Market Approval (PMA) application for its unique CALCIVIS imaging system

Edinburgh, November 2017 – CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that the FDA has accepted its CALCiViS imaging system Pre-Market Approval (PMA) Application for substantive review. The filing of the PMA application to the FDA was made...

CALCiViS announces positive results from PMA clinical study evaluating its unique CALCIVIS® imaging system

Edinburgh, 1 November 2017 – CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces positive results from its pivotal Premarket Approval (PMA) clinical study evaluating its unique CALCiViS imaging system in the assessment of active dental demineralisation. The successful study...

CALCiViS launches new video

What do jellyfish have in common with dental caries? CALCiViS has released a brand new video to illustrate how its innovative technology works – access it at https://vimeo.com/238365978 This video demonstrates how bioluminescence (light-emission) seen in nature, including in marine life such as jellyfish, is now utilised in dentistry to...

CALCiViS closes equity funding to advance imaging system

  Proceeds will be used to file a PMA with FDA and to launch the imaging system in the UK Edinburgh, October 4th 2017 - CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces it has secured new equity funding. ...

CALCiViS to present at the 5th Annual MedTech & Digital Health Forum in Basel, Switzerland

Edinburgh, 22 September 2017 – CALCIVIS, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that its Chief Executive Officer (CEO) Adam Christie will present at the Sachs 5th Annual MedTech & Digital Health Forum on 25 September 2017 at 10:45am CET...

CALCiViS presents imaging system to Parliament

July 12th 2017. CALCiViS imaging system developer and Chief Technical Officer, Bruce Vernon, presents the CALCiViS imaging system to an All Parliamentary Group for Dental innovation as part of the British Dental Industry Associations  "innovation in Dentistry" group. Link to images The session, jointly organised by the British Dental Industry Association...

CALCiViS presents new clinical evidence to International Research Association

July 5th to 8th 2017 - CALCiViS presents five new clinical publications at the 64th International Organisation for Caries Research (ORCA) meeting in Oslo, Norway.   The publications focus entirely on the revolutionary CALCiViS photoprotein and its unique ability to help determine early enamel demineralisation - at a stage when...

FDA filing on track for H2 2017

Edinburgh, 05 June 2017 – CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that it has completed patient recruitment into its PMA clinical study assessing the safety and performance of a commercial version the CALCiViS ® imaging system for...

CALCiViS starts new FDA clinical study

Edinburgh, 09 January   2017 – CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that it has begun recruitment into a clinical study of approximately 100 patients assessing the performance of a commercial version of its CE marked CALCiViS imaging...

CALCiViS at Medtech Showcase 2017

Edinburgh, 10 January 2017 - CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that Chief Executive Officer (CEO), Adam Christie, will present at the Medtech Showcase held at the 9th Annual Biotech Showcase™ today Tuesday, January 10th 2017 at...
Web Design by: Purple Imp